Description
Osteosynt is composed of a balanced combination of hydroxyapatite (HA) and β-tricalcium phosphate (β-TCP), providing both structural stability and controlled resorption. This supports effective bone regeneration while maintaining mechanical integrity throughout the healing process.
With nano-scale porosity and interconnected micro-, meso-, and macropores, Osteosynt creates an ideal environment for cell adhesion, migration, vascularization, and protein adsorption – all essential for successful bone regeneration.
Osteosynt actively functions as a scaffold that promotes cell migration and neovascularization (osteoconductive), and some studies suggest it may also support stem cell differentiation (osteoinductive) without the need for added growth factors.
The material chemically bonds with body fluids and forms a surface apatite layer that enhances osseointegration. It is free from organic residues and provokes a minimal inflammatory response, reducing the risk of immune reaction.
Thanks to its high calcium content, Osteosynt is clearly visible in radiographic imaging, simplifying post-operative follow-up and monitoring.
Available in various forms (granules, blocks, etc.), Osteosynt is easily adaptable to clinical needs. No donor site is required – reducing surgical time, infection risk, and patient morbidity.
With over 35 years of experience and more than 400,000 cases treated, Osteosynt is globally recognized as a gold standard in synthetic bone regeneration – backed by extensive clinical documentation.